You are here: Industry Insights > CLI

News List

18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at VIVA prnasia
October 13, 2021
18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Clinical Trial at VIVA21. The objective of this clinical investigation has been to evaluate safety and performance...
12-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at LINC europeanpharmaceuticalreview
January 29, 2021
12-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Trial at LINC 2021.
Caprion-HistoGeneX Acquires Clinical Logistics contractpharma
January 11, 2021
Caprion-HistoGeneX, a global contract research laboratory services provider has acquired Clinical Logistics Inc. (CLI), a Virtual Central Specimen Management CRO based in Halifax, Canada.
India gives nod to cell therapy for Critical Limb Ischemia (CLI) europeanpharmaceuticalreview
August 25, 2020
Stempeucel®, a cell therapy for the treatment of Critical Limb Ischemia (CLI), has been approved for commercial use in India by the Drug Controller General.
Perfusion Assessment Key for Critical Limb Ischemia Diagnosis drugs
August 13, 2019
Strategies for perfusion assessment necessary for critical limb ischemia (CLI) diagnosis remain limited, according to an American Heart Association scientific statement published online in Circulation.